MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jad.2025.119545

Медицинская библиотека · Journal of affective disorders · 2025

Inflammatory biomarkers as predictors for unlocking antidepressant efficacy: Assessing predictive value and risk stratification in major depressive disorder in a prospective longitudinal study.

Elbakary Nervana, Al-Khuzaei Noriya, Hussain Tarteel, Karawia Ahmed, Smida Malek, Abu-Rahma Niveen, Akel Fairooz, Mahmoud Soad Esmail, Currie James, Khoodoruth Mohamed Adil Shah, Ouanes Sami

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Major depressive disorder (MDD) is characterized by significant heterogeneity in treatment response, with inflammation hypothesized to play a role in its pathophysiology. Peripheral inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP), may predict antidepressant efficacy. This study investigated the association between baseline inflammatory biomarkers, their changes, and antidepressant treatment outcomes in patients with MDD.

METHODS

A prospective longitudinal cohort study in Qatar recruited 123 MDD outpatients (aged 18-64). Baseline assessments included NLR, CRP, monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR). Depression severity was measured via the Zung Self-Rating Depression Scale (ZSRS) at baseline and 12 weeks post-treatment. Statistical analyses, including multiple regression and Random Forest machine learning models, identified predictors of antidepressant response.

RESULTS

Improvement in depressive symptoms was associated with female sex, higher mean corpuscular volume (MCV), lower absolute neutrophil count (ANC), and higher eosinophil counts. However, changes in NLR, MLR, PLR, and CRP did not predict treatment response. Folate levels and PLR were identified by the machine learning model as top predictors, suggesting potential utility as biomarkers for response classification. Our study identified predictors of improvement in suicidal ideation, including hematological markers (lower RBC, higher eosinophils, lower monocytes), younger age, female sex, medical comorbidities, and longer assessment intervals.

CONCLUSION

Baseline ANC and eosinophil count may help stratify MDD treatment outcomes, though post-treatment biomarker changes were not linked to symptom improvement. Our findings highlight suicidality as a distinct pathology within depression, necessitating tailored interventions. This study highlights the complexity of inflammation in depression and suicidality, emphasizing the need for advanced biomarkers utilization in precision medicine and personalized psychiatry treatment.

Для цитирования: Elbakary Nervana, Al-Khuzaei Noriya, Hussain Tarteel, Karawia Ahmed, Smida Malek, Abu-Rahma Niveen, Akel Fairooz, Mahmoud Soad Esmail, Currie James, Khoodoruth Mohamed Adil Shah, Ouanes Sami. Inflammatory biomarkers as predictors for unlocking antidepressant efficacy: Assessing predictive value and risk stratification in major depressive disorder in a prospective longitudinal study.. Journal of affective disorders. 2025. DOI: 10.1016/j.jad.2025.119545.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.